News | Breast Density | March 24, 2016 | Jeff Zagoudis

Indiana Amends Breast Density Inform Legislation

State now requires notification for all patients, regardless of personal fibroglandular density levels

Indiana, breast density notification law, 2016

March 23, 2016 — Indiana Gov. Mike Pence signed an amendment to the state’s 2013 breast density reporting bill Wednesday expanding the requirements for notification. The amended law goes into effect July 1, 2016.

The state had previously enacted Senate Enrolled Act (SEA) 414 three years ago, which required notification in the mammography report if a patient was determined to have dense fibroglandular breast tissue. SEA 414 also required the provision of insurance coverage for supplemental screening for women at least 40 years old determined to have high breast density.

“We never considered it a density reporting bill as the wording stated that women would be notified about their dense tissue only if they needed further follow-up or testing,” said Nancy Cappello, Ph.D., director and founder of advocacy group Are You Dense of the existing legislation. “Density reporting should not be contingent on anything other than reporting the woman’s breast tissue composition.”

The new amendment, designated House Bill (HB) 1272, removes the specific language that only required notification if high breast density was determined. All mammography reports must now include information about fibroglandular breast density, regardless of whether or not the patient is determined to be fibroglandularly dense.

With the approval, Indiana becomes the 25th state to adopt a full breast density notification law. Three other states — New Hampshire, Vermont and Mississippi — have introduced bills in 2016, and a total of eight states are currently debating similar legislation.

For more information: www.areyoudenseadvocacy.org

Related Content

The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Volpara Enterprise Cloud Reaches 1 Million Mammograms Stored
News | Mammography | October 31, 2018
Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic...
Philips Debuts Integrated Breast Ultrasound Solution
News | Ultrasound Women's Health | October 26, 2018
Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq...
Etta Pisano Named American College of Radiology Chief Research Officer
News | Radiology Business | October 25, 2018
October 25, 2018 — Breast imaging research pioneer Etta Pisano, M.D., FACR, has been named...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...